The response to Typhi Vi vaccination is compromised in individuals with primary immunodeficiency
Measurement of an individuals ability to respond to polysaccharide antigens is a crucial test to determine adaptive immunity. Currently the response to Pneumovax® is utilized but with the success of Prevnar®, measurement of the response to Pneumovax may be challenging. The aim of the study was to as...
Hoofdauteurs: | , , , , , , , , , , |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
Elsevier
2017-06-01
|
Reeks: | Heliyon |
Onderwerpen: | |
Online toegang: | http://www.sciencedirect.com/science/article/pii/S2405844017309416 |